CRYOPORT, INC. Class of Warrant or Right, Outstanding
CRYOPORT, INC. (CYRX) had Class of Warrant or Right, Outstanding of 3.54 million shares as of 2014-12-31, per its 10-Q filed 2015-02-05.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2015-02-05
- 2014-12-31: Class of Warrant or Right, Outstanding 3.54M shares.
- 2014-09-30: Class of Warrant or Right, Outstanding 2.68M shares.
- 2014-06-30: Class of Warrant or Right, Outstanding 2.00M shares.
- 2014-03-31: Class of Warrant or Right, Outstanding 262.86K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2014-12-31 | 3.54M shares 10-Q · filed 2015-02-05 |
| 2014-09-30 | 2.68M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 2.00M shares 10-Q · filed 2014-07-31 |
| 2014-03-31 | 262.86K shares 10-K · filed 2014-06-25 |
| 2013-12-31 | 220.50K shares 10-Q · filed 2014-02-13 |
| 2013-03-31 | 312.86K shares 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |